Tenax Therapeutics, Inc. (TENX) News
Track canonical SquawkNews coverage tagged to TENX, Tenax Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 11 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
US Stocks Edge Lower; Monday.Com Shares Tumble After Q2 Results
U.S. stocks traded mostly lower this morning, with the Dow Jones index falling around 0.2% on Monday. Following the market opening Monday, the Dow traded down 0.16% to 53,949.06 while the NASDAQ fell 0.07% to 26,672.55.
EARNINGS | Aug 10, 2026, 01:40 PM UTC
H
Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday. Shares of Airsculpt Technologies Inc (NASDAQ: AIRS ) fell sharply in pre-market trading following second-quarter results. Ai
EARNINGS | Aug 10, 2026, 12:02 PM UTC
L
TENX Tenax Therapeutics RESULTS: Q2, Q2 operating expenses $18.784M, Q2 Operating Income $-18.784M, Q2 Net Income $-17.803M
TENX Tenax Therapeutics RESULTS: Q2, Q2 operating expenses $18.784M, Q2 Operating Income $-18.784M, Q2 Net Income $-17.803M
EARNINGS | Jul 31, 2026, 11:01 AM UTC
L
TENX - Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
TENX - Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
EARNINGS | Jul 31, 2026, 11:00 AM UTC
L
TENX Initiated at Buy and $35 PT @ Canaccord
TENX Initiated at Buy and $35 PT @ Canaccord
EQUITY | Jul 28, 2026, 01:17 PM UTC
L
TENX new Outperform W/ $39 PT @ Evercore
TENX new Outperform W/ $39 PT @ Evercore
EQUITY | Jul 22, 2026, 12:48 PM UTC
H
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Liminatus Pharma (NASDAQ: LIMN ) stock increased by 40.9% to $0.16 during Thursday's pre-market session. The market value of their outstanding shares is at $5.8 million. Stablecoin Development (AMEX: SDEV ) stock
EARNINGS | Jul 02, 2026, 12:05 PM UTC
H
Tenax Therapeutics shares are trading higher after the company announced that it will present results from the Phase 3 LEVEL clinical trial
Tenax Therapeutics shares are trading higher after the company announced that it will present results from the Phase 3 LEVEL clinical trial in a Late-Breaking Clinical Science session at the European Society of Cardiolog
GEOPOLITICS | Jul 02, 2026, 11:46 AM UTC
H
Tenax Therapeutics To Present Results From Phase 3 LEVEL Clinical Trial In Late-Breaking Clinical Science Session At ESC Congress 2026
Abstract recently submitted in anticipation of initial data analysis ahead of ESC Company expects to report topline LEVEL results in August CHAPEL HILL, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (N
GEOPOLITICS | Jul 02, 2026, 11:03 AM UTC
M
TENX: Guggenheim Raises PT
Guggenheim maintains buy rating on Tenax Therapeutics and raises price target to $40
EQUITY | Jun 22, 2026, 01:40 PM UTC
M
TENX: Chardan Initiates Buy
Chardan Capital initiates coverage on Tenax Therapeutics with a buy rating and a price target of $27
EQUITY | Jun 22, 2026, 12:50 PM UTC